Literature DB >> 4293531

[Treatment of hyperuricemic and gouty patients with derivatives of benzofuran].

F Delbarre, C Auscher, J L Olivier, A Rose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4293531

Source DB:  PubMed          Journal:  Sem Hop


× No keyword cloud information.
  8 in total

1.  [Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)].

Authors:  D Janzen; D P Mertz; E Scheiffele; O Kühnhold
Journal:  Klin Wochenschr       Date:  1977-11-01

2.  Metabolism of benzbromarone in man.

Authors:  J Broekhuysen; M Pacco; R Sion; L Demeulenaere; M Van Hee
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

3.  [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].

Authors:  N Zöllner; W Dofel; W Gröbner
Journal:  Klin Wochenschr       Date:  1970-04-01

Review 4.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

5.  [Inhibition of enzymes of the internal mitochondrial membrane by benzbromarone].

Authors:  R Kramar; M M Müller
Journal:  Experientia       Date:  1973-04-15

6.  Pharmacokinetics and biotransformation of benzbromarone in man.

Authors:  H Ferber; H Vergin; G Hitzenberger
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.

Authors:  I Walter-Sack; J X de Vries; A Ittensohn; M Kohlmeier; E Weber
Journal:  Klin Wochenschr       Date:  1988-02-15

8.  The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.